» Articles » PMID: 30562061

Youth with Type 2 Diabetes Have Hepatic, Peripheral, and Adipose Insulin Resistance

Overview
Date 2018 Dec 19
PMID 30562061
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Adolescents with type 2 diabetes (T2D) have severe insulin resistance (IR) secondary to obesity, genetics, and puberty, and IR predicts metabolic comorbidities. Adults with T2D have multitissue IR, which has guided therapeutic developments, but this is not established in youth. We sought to assess adipose, hepatic, and peripheral insulin sensitivity in adolescents with and without T2D. Twenty-seven youth with T2D [age: 15.6 ± 0.4 yr; female: 78%; body mass index (BMI) percentile: 96.1 (52.6, 95.9), late puberty; hemoglobin A1c (HbA1c) 7.3% (6.2, 10.1)] and 21 controls of similar BMI, pubertal stage, and habitual activity were enrolled. Insulin action was measured with a four-phase hyperinsulinemic-euglycemic clamp (basal, 10, 16, and 80 mU·m·min for studying adipose, hepatic, and peripheral IR, respectively) with glucose and glycerol isotope tracers. Total fat mass, fat-free mass, liver fat fraction, and visceral fat were measured with dual-energy x-ray absorptiometry (DXA) and MRI, respectively. Free fatty acids (FFAs), lipid profile, and inflammatory markers were also measured. Adolescents with T2D had higher lipolysis ( P = 0.012), endogenous glucose production ( P < 0.0001), and lower glucose clearance ( P = 0.002) during hyperinsulinemia than controls. In T2D, peripheral IR positively correlated to FFA ( P < 0.001), inflammatory markers, visceral ( P = 0.004) and hepatic fat ( P = 0.007); hepatic IR correlated with central obesity ( P = 0.004) and adipose IR ( P = 0.003). Youth with T2D have profound multitissue IR compared with BMI-equivalent youth without T2D. The development of multitissue interactions appears crucial to the pathogenesis of T2D. Therapeutic targets on multitissue IR may be of benefit, deserving of further research.

Citing Articles

Racial and ethnic sleep health disparities in adolescents and risk for type 2 diabetes: a narrative review.

Clark E, Gutierrez-Colina A, Ruzicka E, Sanchez N, Bristol M, Gulley L Ann Med. 2024; 56(1):2399756.

PMID: 39253865 PMC: 11389628. DOI: 10.1080/07853890.2024.2399756.


Glycemia and Gluconeogenesis With Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.

Dietsche K, Magge S, Dixon S, Davis F, Krenek A, Chowdhury A J Clin Endocrinol Metab. 2023; 109(5):1361-1370.

PMID: 37967247 PMC: 11031226. DOI: 10.1210/clinem/dgad669.


Reduced Growth Hormone Predicts Worsening Adipose Tissue Insulin Resistance in Adults with Obesity.

Li X, Zhou B, Yao Y, Wang G, Meng H Obes Facts. 2023; 16(4):401-410.

PMID: 37231915 PMC: 10427958. DOI: 10.1159/000530734.


Correspondence on Editorial regarding "Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations".

Lee J, Park K, Lee H, Park H, Han J, Ahn S Clin Mol Hepatol. 2022; 29(1):185-187.

PMID: 36353767 PMC: 9845667. DOI: 10.3350/cmh.2022.0375.


Mathematical modeling reveals differential dynamics of insulin action models on glycerol and glucose in adolescent girls with obesity.

Hampton G, Bartlette K, Nadeau K, Cree-Green M, Diniz Behn C Front Physiol. 2022; 13:895118.

PMID: 35991189 PMC: 9388790. DOI: 10.3389/fphys.2022.895118.


References
1.
Basu R, Basu A, Johnson C, Schwenk W, Rizza R . Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes. 2004; 53(8):2042-50. DOI: 10.2337/diabetes.53.8.2042. View

2.
Weiss R, Dufour S, Taksali S, Tamborlane W, Petersen K, Bonadonna R . Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet. 2003; 362(9388):951-7. PMC: 2995523. DOI: 10.1016/S0140-6736(03)14364-4. View

3.
Bacha F, Pyle L, Nadeau K, Cuttler L, Goland R, Haymond M . Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012; 13(5):376-83. PMC: 3355206. DOI: 10.1111/j.1399-5448.2011.00841.x. View

4.
Steer P, Basu S, Lithell H, Vessby B, Berne C, Lind L . Acute elevations of medium- and long-chain fatty acid have different impacts on endothelium-dependent vasodilation in humans. Lipids. 2003; 38(1):15-9. DOI: 10.1007/s11745-003-1025-9. View

5.
Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, Arslanian S . A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012; 366(24):2247-56. PMC: 3478667. DOI: 10.1056/NEJMoa1109333. View